In supervised protocols, BPC-157 is commonly dosed at 250 to 500 mcg per day subcutaneously, while TB-500 uses about 2.5 mg twice weekly for weeks 1 to 6, then about 2.5 mg once weekly for maintenance
2020 Mar 15;14(2):153-167
References: Wu, G., Fang, Y
Thus, energy deficiency, depleted levels of energy substrates, and glutathione depletion are widespread systemic features of AKI
refrigerate or freeze for long-term research use Intended Use : In vitro assays, animal model studies, regenerative medicine research only This BPC-157 TB-500 10mg blend is supplied exclusively for laboratory research to support investigations into peptide-mediated healing, angiogenesis, and tissue regeneration
Follow the BPC-157 cycle length: 4 to 6 weeks on, 2 to 4 weeks off